ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,790Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 783

$1.68M Total Retail Price of All Prescriptions

Rank: 7 out of 783

566 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 566 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

29% of this provider’s 566 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 19,335 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
HYDROCODONE-ACETAMINOPHEN 1,006 638 S3 1 2
LEVOTHYROXINE SODIUM 793 672 2 1
SIMVASTATIN 766 581 3 3
OMEPRAZOLE 702 475 4 6
LISINOPRIL 701 576 5 4
AMLODIPINE BESYLATE 633 518 6 5
DONEPEZIL HCL 593 539 7 24
METOPROLOL TARTRATE 575 443 8 9
FUROSEMIDE 568 470 9 7
GABAPENTIN 427 313 10 15
CYMBALTA 399 287 11 35
MIRTAZAPINE 393 353 12 52
WARFARIN SODIUM 364 285 13 10
POTASSIUM CHLORIDE 356 310 14 16
SERTRALINE HCL 355 291 15 22
TRAMADOL HCL 331 268 16 20
NAMENDA 329 303 17 32
CITALOPRAM HBR 314 252 18 19
RISPERIDONE 277 209 19 67
TRAZODONE HCL 260 147 20 39
POLYETHYLENE GLYCOL 3350 244 184 21 43
CARVEDILOL 233 204 22 21
CEPHALEXIN 226 196 23 70
METFORMIN HCL 226 148 23 8
PRAVASTATIN SODIUM 213 139 25 14
ZOLPIDEM TARTRATE 213 159 25 23
LANTUS 211 157 27 38
DIVALPROEX SODIUM 209 178 28 72
HYDROCHLOROTHIAZIDE 204 141 29 12
JANUVIA 201 184 30 73
ATENOLOL 188 182 31 17
ABILIFY 187 107 32 148
CLOPIDOGREL 182 148 33 29
ADVAIR DISKUS 180 148 34 50
RANITIDINE HCL 175 143 35 44
SPIRONOLACTONE 174 165 36 57
OLANZAPINE 169 76 37 108
METOPROLOL SUCCINATE 168 126 38 13
QUETIAPINE FUMARATE 166 144 39 79
OXYCODONE-ACETAMINOPHEN 164 77 S2 40 76
LOSARTAN POTASSIUM 163 139 41 18
CLOZAPINE 160 55 42 222
TAMSULOSIN HCL 160 119 42 26
OXYCODONE HCL-ACETAMINOPHEN 157 62 S2 44 86
CIPROFLOXACIN HCL 156 141 45 62
SPIRIVA 152 132 46 59
BACLOFEN 145 85 47 125
PLAVIX 144 120 48 51
PREDNISONE 140 123 49 36
FENTANYL 139 64 S2 50 65
BENZTROPINE MESYLATE 137 96 R 51 198
OXYBUTYNIN CHLORIDE ER 137 93 51 117
NYSTATIN 134 110 53 106
SULFAMETHOXAZOLE-TRIMETHOPRIM 134 124 53 95
PANTOPRAZOLE SODIUM 132 94 55 30
CLONIDINE HCL 128 77 56 60
LEVETIRACETAM 123 83 57 89
LIDODERM 123 118 57 132
HUMALOG 119 110 59 101
IPRATROPIUM-ALBUTEROL 117 115 60 110
MELOXICAM 115 82 61 37
ATORVASTATIN CALCIUM 113 94 62 11
ROPINIROLE HCL 111 85 63 74
NEXIUM 110 63 64 28
HYDRALAZINE HCL 110 100 64 78
ESCITALOPRAM OXALATE 109 80 66 54
FAMOTIDINE 105 78 67 55
ISOSORBIDE MONONITRATE ER 105 100 67 40
FLUOXETINE HCL 103 81 69 45
AMOX TR-POTASSIUM CLAVULANATE 103 94 69 128
NOVOLOG 98 63 71 81
MORPHINE SULFATE ER 97 46 S2 72 107
VENLAFAXINE HCL ER 97 60 72 100
IBUPROFEN 95 47 74 115
ALLOPURINOL 94 75 75 31
TIZANIDINE HCL 94 50 75 133
LAMOTRIGINE 93 42 77 156
HALOPERIDOL 93 61 77 216
OXYCODONE HCL 92 22 S2 79 123
CARBIDOPA-LEVODOPA 92 78 79 88
NAPROXEN 91 48 81 104
NITROFURANTOIN 91 90 81 225
BUPROPION HCL SR 89 56 83 166
CYCLOBENZAPRINE HCL 85 24 R 84 63
BYSTOLIC 85 67 84 99
AZITHROMYCIN 83 58 86 41
GLIPIZIDE 83 60 86 71
EXELON 80 71 88 109
FENOFIBRATE 78 53 89 66
ALENDRONATE SODIUM 78 68 89 25
KLOR-CON M20 77 49 91 48
ENDOCET 74 0 S2 92 286
DIGOXIN 73 65 93 61
PROMETHAZINE HCL 73 36 R 93 97
VOLTAREN 73 50 93 251
PROAIR HFA 71 36 96 56
LEVOFLOXACIN 68 57 97 75
COMBIVENT 68 45 97 120
FLUTICASONE PROPIONATE 66 41 99 46
ZETIA 66 39 99 80
DIVALPROEX SODIUM ER 65 27 101 180
TRANSDERM-SCOP 63 53 102 275
LOVAZA 60 51 103 163
CLONIDINE 60 43 103 254
TRIAMTERENE-HCTZ 59 51 105 42
OXYBUTYNIN CHLORIDE 59 50 105 96
LOPERAMIDE 58 50 107 244
DIOVAN 57 50 108 49
MORPHINE SULFATE 56 53 S2 109 218
OXYCONTIN 55 25 S2 110 171
SODIUM CHLORIDE 55 55 110 206
GLIMEPIRIDE 54 47 112 34
DOXAZOSIN MESYLATE 51 25 113 87
LANTUS SOLOSTAR 51 18 113 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.